arginyl-glycyl-aspartic acid has been researched along with Leishmaniasis, American in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, M; Gomez, EA; Hashiguchi, Y; Ishimaru, Y; Iwata, H; Kato, H; Mimori, T; Uezato, H | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Leishmaniasis, American
| Article | Year |
|---|---|
Ayadualin, a novel RGD peptide with dual antihemostatic activities from the sand fly Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis.
Topics: Animals; Blood Coagulation; Dose-Response Relationship, Drug; Factor XIIa; Humans; Insect Proteins; Insect Vectors; Leishmaniasis, Cutaneous; Oligopeptides; Psychodidae | 2015 |